Message Font: Serif | Sans-Serif
 
No. of Recommendations: 11
CNS is trading today around $9.50 as of this posting. This is the lowest
the stock has been since last July. However, now the company has $49M
in cash instead of $41M, which translates to $3.50 a share. Also, the
dividend now stands at 0.2/9.5 = 2.1%. It's trading at 2.4 times book
value. Still no debt. Matt Richey valued the rock-bottom value of
the stock in the September issue at $9.78 assuming no growth.

The downside? Some question marks about growth, which is understandable.
The ability of management to market Breathe Right successfully for
growth is under question, as well as develop new products (although
the fiber tablets and snore relief seem to be doing at least okay).

I think what's attractive about this stock is it's relative safety and
dividend. It somewhat resembles FDP in that it has a good margin of
safety, a decent dividend, but questionable long-term growth prospects.
This makes it at the very least a decent short-term market hedge, with
a decent (but certainly not guaranteed) upside.

If this goes much lower, I will probably buy even more. What price it
will take for me to buy I still uncertain of, but it's getting darned close.


Thanks for reading! :)

Tom
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.